Medical Research Charities > News > Drug distribution becomes weapon to block competition – San Diego Union Tribune

Drug distribution becomes weapon to block competition – San Diego Union Tribune

WASHINGTON (AP) — The same strategy that Martin Shkreli used to get away with a 5,000-percent price increase on an old drug is used by many other drugmakers to maintain sky-high prices on billions of dollars’ worth of medications.

Before the price hike that made him infamous, the former CEO of Turing Pharmaceuticals had to ensure that no competitor would be able to launch a cheaper version of Daraprim, the 60-year-old anti-infection pill that is no longer under patent.

Shkreli had the perfect weapon: a tightly-controlled distribution system which would make it virtually impossible for a competitor to obtain enough Daraprim to develop their own version.

Click here to read the full story by Matthew Perrone, San Diego Union Tribune.